The FDA has granted GenMark Diagnostics 510(k) clearance for its ePlex Blood Culture Identification Gram-Negative Panel, which is designed to detect bloodstream infections that can lead to sepsis. The device is the third ePlex BCID panel from GenMark to secure FDA clearance during the past four months.
FDA clears GenMark's gram-negative diagnostic panel
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.